Timetable: Post-authorisation measure (PAM) assessed by PRAC
Submitted by Anonymous (not verified) on 14 October 2025 - 9:00
Timetable: Post-authorisation measure (PAM) assessed by PRAC
Respiporc Flu3 : EPAR - Medicine overview
Submitted by Anonymous (not verified) on 14 October 2025 - 9:00
Respiporc Flu3 : EPAR - Medicine overview
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Submitted by Anonymous (not verified) on 14 October 2025 - 7:58
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Respiporc Flu3 : EPAR - All Authorised presentations
Submitted by Anonymous (not verified) on 14 October 2025 - 1:00
Respiporc Flu3 : EPAR - All Authorised presentations
Suvaxyn Circo+MH RTU : EPAR - Public assessment report
Submitted by Anonymous (not verified) on 14 October 2025 - 0:00
Suvaxyn Circo+MH RTU : EPAR - Public assessment report
Respiporc Flu3 : EPAR - Scientific Discussion
Submitted by Anonymous (not verified) on 14 October 2025 - 0:00
Respiporc Flu3 : EPAR - Scientific Discussion
Human medicines European public assessment report (EPAR): Mycamine, micafungin, Date of authorisation: 25/04/2008, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 13 October 2025 - 16:15
Human medicines European public assessment report (EPAR): Mycamine, micafungin, Date of authorisation: 25/04/2008, Revision: 22, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prac-tic, pyriprole, Status: Authorised
Submitted by Anonymous (not verified) on 13 October 2025 - 13:26
Veterinary medicines European public assessment report (EPAR): Prac-tic, pyriprole, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Posatex, orbifloxacin,mometasone furoate,posaconazole, Status: Authorised
Submitted by Anonymous (not verified) on 13 October 2025 - 13:15
Veterinary medicines European public assessment report (EPAR): Posatex, orbifloxacin,mometasone furoate,posaconazole, Status: Authorised
Annex to agenda of the CHMP meeting 13-16 October 2025
Submitted by Anonymous (not verified) on 13 October 2025 - 12:24
Annex to agenda of the CHMP meeting 13-16 October 2025